|
Domain: Biomedicine and Molecular Biosciences
Action B35:
Lipid Peroxidation Associated Disorders: LPO
|
European
Cooperation in the field of Scientific and Technical Research
COST
B35 Action
Lipid
Peroxidation Associated Disorders: LPO
The main objective of the Action is to improve understanding, monitoring and control of lipid peroxidation in medicine and related biosciences and technologies.
Secondary objectives
- improve methods for detection and quantitation of lipid peroxidation for use in research and subsequent application (through biotechnology) to clinical science;
- determine the prevalence of lipid peroxidation products in various inflammatory diseases and its correlation to disease severity or outcome;
- elucidate the metabolism of important lipid peroxidation products and improve our understanding of their proinflammatory and other biological effects;
- develop and test novel antioxidants that could have future applications in therapy for inflammatory diseases.
| B35
Action Chair: |
Neven Zarkovic
(zarkovic@irb.hr ) |
| Vice-Chair:
|
Tilman Grune (grune@uni-hohenheim.de) |
Management Committee
Coordinator: |
Nesrin Kartal Özer (nkozer@marmara.edu.tr) |
| Participants: |
49 teams -
200 scientists from 26 European countries + USA, Canada and Japan
|
| COST
Domain: |
Biomedicine & Molecular Biosciences
www.cost.esf.org/domains_actions/bmbs
Rapporteur : Professor Marieta COSTACHE
Science Officer : Kalliopi KOSTELIDOU
Administrative Officer : Ms Gabriela CRISTEA
|
|
|
|
| Work Groups: |
|
|
| |
Improvement of methods for the determination
of LPO products
|
|
| |
Work group
management: |
|
| |
|
Corinne Spickett
(chair) |
| |
|
Manuel Portero-Otin
(vice-chair) |
| |
|
Franz Tatzber
& Willibald Wonisch (coordinators) |
| |
|
|
| |
Studies of the fundamental aspects of LPO |
|
| |
Work group
management: |
|
| |
|
Francoise Gueraud
(chair) |
| |
|
Peter Eckl
(vice-chair) |
| |
|
Mustafa Atalay (coordinator) |
| |
|
|
| |
Pathological
aspects of LPO |
|
| |
Work group
management: |
|
| |
|
Anne Negre-Salvayre
(chair) |
| |
|
Werner Siems
(vice-chair) |
| |
|
Maria-Teresa
Mitjavilla (coordinator) |
| |
|
|
| |
Development and validation of antioxidants |
|
| |
Work group
management: |
|
| |
|
Grezgorz Bartosz
(chair) |
| |
|
Lubica Horakova
(vice-chair) |
| |
|
Rimantas Venskutonis
(coordinator) |
Action
details:
CSO approval date : 29/03/2006
Entry into force : 11/05/2006
End of Action : 01/06/2010 |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
Country
|
Date
of signatures |
|
Country
|
Date
of signatures |
|  Belgium
|
11.05.2006. |
|
|  Czech Republic
|
11.05.2006. |
|
 Bulgaria |
preparing to sign |
|  Lithuania
|
11.05.2006. |
|
|
|
 Poland |
11.05.2006. |
|
|
|
 United Kingdom |
11.05.2006. |
|
|
|
 Italy |
17.05.2006. |
|
|
|
 Slovakia |
17.05.2006. |
|
|
|
 Austria |
18.05.2006. |
|
|
|
 Croatia |
18.05.2006. |
|
|
|
 Germany
|
18.05.2006. |
|
|
|
 Hungary
|
18.05.2006. |
|
|
|
|  Latvia
|
29.05.2006. |
|
|
|
 Spain
|
29.05.2006. |
|
|
|
 Finland
|
12.07.2006. |
|
|
|
 Romania
|
20.07.2006. |
|
|
|
 France |
03.10.2006. |
|
|
|
 Turkey |
17.10.2006. |
|
|
|
 Israel |
05.12.2006. |
|
|
|
|  Serbia
|
06.02.2007. |
|
|
|
 Cyprus |
27.02.2007. |
|
|
|
|  Norway
|
16.03.2007. |
|
|
|
 Greece |
20.03.2007. |
|
|
|
 Portugal |
24.10.2007. |
|
|
|
 Denmark |
27.06.2008. |
|
|
|
|
|
|
|
|
Non-Cost Countries |
|
|
|
|
 United States of America |
|
|
|
|
|  Japan
|
|
|
|
|
 Ukraine |
|
|
|
|
 Canada |
|
|
|
|
Download MoU
Download Progress Report
Action B35 Fact Sheet
More information
can be obtained by contacting the Chair of the Action:
Professor Neven
Zarkovic
zarkovic@irb.hr
| 
webmail
RBI Home 
search
